Chen Tong, Cui Yu, Chen Hui-Sheng
Department of Neurology, General Hospital of Northern Theater Command, ShenYang, PR China.
Heliyon. 2024 Jun 6;10(11):e32630. doi: 10.1016/j.heliyon.2024.e32630. eCollection 2024 Jun 15.
Sex differences in acute ischemic stroke have been widely investigated, but the difference in acute ischemic stroke patients who received intravenous thrombolysis is not well understood. The current study was to investigate the issue based on a prospective cohort.
From the Intravenous Thrombolysis Registry for Chinese Ischemic Stroke within 4.5h onset (INTRECIS) cohort, a total of 953 eligible patients with acute ischemic stroke were enrolled in final analysis. Based on 3-month modified Rankin scale score (mRS), patients were classified into good outcome group (mRS 0-1) and poor outcome group (mRS 2-6). Univariate and multivariate logistic regression analyses were used to identify predictive factors for clinical outcome in male or female patients.
Of the 953 patients treated with intravenous thrombolysis, 314 (32.9 %) were women. At day 90, we found no significant gender differences in good outcome (72.5 % vs 65.6 %, adjusted p = 0.414). We got the same results after propensity score matching (69.5 % vs 63.4 %, adjusted p = 0.637). Furthermore, we found that initial National Institute of Health Stroke Scale (NIHSS) score (odd ratio [OR] 0.877; 95 % CI 0.847-0.909, p < 0.001) and serum creatinine (OR 0.993; 95 % CI 0.986-1.000, p = 0 0.043) were found to be independent risk factors for poor outcome in male patients, while initial NIHSS score (OR 0.879; 95 % CI 0.839-0.920, p < 0.001), age (OR 0.970; 95 % CI 0.946-0.995, p = 0.017), systolic blood pressure (OR 0.984; 95 % CI 0.972-0.996, p = 0.007) and small artery occlusion (OR 2.718; 95 % CI 1.065-6.936, p = 0.036) in female patients.
In this study, we found no gender difference in clinical outcome of thrombolysed stroke patients, but a difference in risk factors predicting outcome in male vs female patients was identified for the first time.
急性缺血性卒中的性别差异已得到广泛研究,但接受静脉溶栓治疗的急性缺血性卒中患者的差异尚不清楚。本研究基于前瞻性队列对此问题进行调查。
从发病4.5小时内的中国缺血性卒中静脉溶栓登记研究(INTRECIS)队列中,共纳入953例符合条件的急性缺血性卒中患者进行最终分析。根据3个月改良Rankin量表评分(mRS),将患者分为预后良好组(mRS 0-1)和预后不良组(mRS 2-6)。采用单因素和多因素逻辑回归分析确定男性或女性患者临床结局的预测因素。
在953例接受静脉溶栓治疗的患者中,314例(32.9%)为女性。在第90天时,我们发现预后良好方面无显著性别差异(72.5%对65.6%,校正p = 0.414)。倾向评分匹配后结果相同(69.5%对63.4%,校正p = 0.637)。此外,我们发现初始美国国立卫生研究院卒中量表(NIHSS)评分(比值比[OR] 0.877;95%可信区间0.847-0.909,p < 0.001)和血清肌酐(OR 0.993;95%可信区间0.986-1.000,p = 0.043)是男性患者预后不良的独立危险因素,而女性患者的独立危险因素为初始NIHSS评分(OR 0.879;95%可信区间0.839-0.920,p < 0.001)、年龄(OR 0.970;95%可信区间0.946-0.995,p = 0.017)、收缩压(OR 0.984;95%可信区间0.972-0.996,p = 0.007)和小动脉闭塞(OR 2.718;95%可信区间1.065-6.936,p = 0.036)。
在本研究中,我们发现溶栓治疗的卒中患者临床结局无性别差异,但首次发现男性和女性患者预后预测危险因素存在差异。